Hyejin Cho

6PUBLICATIONS
56CO-AUTHORS
Innate immunityMolecular targetsPredictive and prognostic markersMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 24, 2026
Stem-like memory-T maintenance and differentiation into tissue-resident T cells sustain chronic graft-versus-host disease in mice.

Xiaohui Kong, Bixin Wang, Xiwei Wu

|Dec 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. Antioxidants 2025, 14, 345.

Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu

|Apr 14, 2025
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate.

Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu

|Oct 13, 2023
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer.

Atish Mohanty, Arin Nam, Saumya Srivastava

|Sep 01, 2023
Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis.

Bin Zhang, Dandan Zhao, Fang Chen

|Mar 31, 2022
Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer.

Thanh H Dellinger, Ernest S Han, Mustafa Raoof

Pageof 1

Frequent Collaborators

3 joint publications

Thanh H Dellinger

3 joint publications

Daniel Schmolze

2 joint publications

Ernest S Han

2 joint publications

Javier Arias-Stella